Obstructive emphysema
Obstructive pulmonary emphysema is a disease characterized by persistent expansion and dilation of the distal air sac cavity of the terminal bronchioles (including respiratory bronchioles, alveolar ducts, alveolar sacs and alveoli), accompanied by destruction of the air cavity wall structure without obvious fibrosis. This disease is often caused by chronic bronchitis induced by long-term smoking, air pollution, inhalation of harmful chemicals and dust, and chronic recurrent respiratory tract infections, which further develop into this disease.
-
Site of disease:
lung -
Infectious :
Not contagious -
Frequent population:
Smokers and chronic bronchitis patients -
Related symptoms:
Barrel chest Chest tightness Dyspnea on exertion Decreased breath sounds Shortness of breath -
Concurrent disease:
Related Drugs
Theophylline sustained-release tablets
Indication: It is suitable for relieving wheezing symptoms of bronchial asthma, asthmatic bronchitis, obstructive pulmonary emphysema, etc.; it can also be used for asthma caused by cardiogenic pulmonary edema.
Manufacturer:
Shandong LINUO Pharmaceutical Company Limited
Theophylline sustained-release tablets
Indication: It is mainly used to treat bronchial asthma, cardiac asthma, emphysema, chronic bronchitis, etc.; it can also be used for diuresis and swelling reduction of cardiogenic and renal edema.
Manufacturer:
Jilin Yatai Pharmaceutical Co., Ltd.
Theophylline sustained-release tablets
Indication: It is suitable for relieving wheezing symptoms such as bronchial asthma, asthmatic bronchitis, obstructive pulmonary emphysema, etc.
Manufacturer:
China Resources Zizhu Pharmaceutical Co., Ltd.
Theophylline sustained-release tablets
Indication: It is suitable for relieving wheezing symptoms of bronchial asthma, asthmatic bronchitis, obstructive pulmonary emphysema, etc.; it can also be used for asthma caused by cardiogenic pulmonary edema.
Manufacturer:
Shandong Xinhua Pharmaceutical Company Limited
Diphylline Injection
Indication: It is suitable for bronchial asthma, asthmatic bronchitis, obstructive pulmonary emphysema, etc. to relieve wheezing symptoms. It is also used for asthma caused by cardiogenic pulmonary edema.
Manufacturer:
Shiyao YINHU Pharmaceutical Co., Ltd.
Lung Heart Tablets
Manufacturer:
Jiangsu 707 Natural Pharmaceutical Co., Ltd.
Aminophylline Tablets
Indication: It is suitable for relieving wheezing symptoms of bronchial asthma, asthmatic bronchitis, obstructive pulmonary emphysema, etc.; it can also be used for asthma caused by cardiogenic pulmonary edema.
Manufacturer:
ORxes Biopharmaceuticals (Shenyang) Co., Ltd.
Aminophylline Tablets
Manufacturer:
Puyang Huiyuan Pharmaceutical Co., Ltd.
Aminophylline
Indication: It is suitable for relieving wheezing symptoms of bronchial asthma, asthmatic bronchitis, obstructive pulmonary emphysema, etc.; it can also be used for asthma caused by cardiogenic pulmonary edema.
Aminophylline sustained-release tablets
Indication: It is suitable for relieving wheezing symptoms of bronchial asthma, asthmatic bronchitis, obstructive pulmonary emphysema, etc.; it can also be used for asthma caused by cardiogenic pulmonary edema.
Manufacturer:
Changchun Norman Bethune Pharmaceutical Co., Ltd.
Related Ingredients
-
Theophylline list
58-55-9 -
Diprophylline list
479-18-5 -
Psoralen list
66-97-7 -
4,4'-Dihydroxybenzophenone list
611-99-4 -
Aminophylline list
317-34-0